REMINDER: Medivation to Host Conference Call and Webcast Providing Detailed Review of Talazoparib on July 6, 2016
July 06 2016 - 7:00AM
Business Wire
Medivation, Inc. (Nasdaq:MDVN) today issued a reminder that it
will host an investor conference call and live audio webcast on
Wednesday, July 6, 2016 at 4:30 p.m. Eastern Time to provide a
detailed review of its promising and potentially best-in-class PARP
inhibitor talazoparib.
Interested parties may access the live audio webcast and
presentation materials by visiting the Investors section of the
company's website at http://investors.medivation.com/events.cfm.
Please connect to the website 10 minutes prior to the start of the
conference call to ensure adequate time for any software downloads
that may be necessary to listen to the webcast.
Conference Call Details:
- U.S. Dial-in number: 877-303-2523
- International Dial-in number:
+1-253-237-1755
- Conference ID: 43737965
Following the live event, a replay of the audio webcast and
presentation materials will be available for at least 30 days on
the Investors section of the company's website at
http://investors.medivation.com/events.cfm.
About Medivation, Inc.
Medivation, Inc. is a biopharmaceutical company focused on the
development and commercialization of medically innovative therapies
to treat serious diseases for which there are limited treatment
options. Medivation aims to transform the treatment of these
diseases and offer hope to critically ill patients and their
families. For more information, please visit us at
http://www.medivation.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160706005698/en/
Medivation, Inc.Anne Bowdidge, 650-218-6900
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Sep 2023 to Sep 2024